SuperworthBiohaven market cap BHVN
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $2.1B
- Highest close in our data
- $5.1B
- Oct 2024
Biohaven is worth $2.1B at the close on Oct 23, 2026, at $13.88 a share.
That is up 19% over the last year.
Its highest close in our data was $5.1B in Oct 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.1B | $1.1B | $2.4B | +78% |
| 2025 | $1.2B | $873.8M | $4.2B | −68% |
| 2024 | $3.7B | $3B | $5.1B | +8% |
| 2023 | $3.4B | $875.8M | $3.4B | +263% |
| 2022 | $946.1M | $934.5M | $1.1B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Biohaven's size, closest first, today.
| Company | Market cap |
|---|---|
| BHVNBiohaven | $2.1B |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ANIPANI Pharmaceuticals | $1.7B |
| NRIXNurix Therapeutics | $2.8B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OGNOrganon | $3.6B |
| OMEROmeros | $1.2B |
| LQDALiquidia | $3.8B |
| Peer median | $1.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Biohaven
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.